GCTK
GlucoTrack Inc
NASDAQ: GCTK · HEALTHCARE · MEDICAL DEVICES
$1.82
-29.46% today
Updated 2026-09-25
Market cap
$2.04M
P/E ratio
0.15
P/S ratio
526.95x
EPS (TTM)
$17.25
Dividend yield
—
52W range
$2 – $136
Volume
12.0M
GlucoTrack Inc (GCTK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-527.00%
ROA
-164.50%
Debt/equity
-0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2009 | — | $-1.20M | — | — | — |
| 2010 | — | $-2.79M | — | — | — |
| 2011 | — | $-2.36M | — | — | — |
| 2012 | — | $-2.77M | — | — | — |
| 2013 | — | $-9.80M | — | — | — |
| 2014 | $59775.00 | $2.98M | 100.00% | 6,034.90% | 4,986.07% |
| 2015 | $143167.00 | $-5.84M | 68.64% | 3,251.69% | -4,080.67% |
| 2016 | $611689.00 | $-5.41M | 90.26% | 924.63% | -884.39% |
| 2017 | $589462.00 | $-10.33M | 76.21% | 1,794.15% | -1,752.24% |
| 2018 | $43488.00 | $-6.72M | -119.75% | 15,035.41% | -15,442.01% |
| 2019 | $208000.00 | $-3.52M | 100.00% | 1,685.58% | -1,690.38% |
| 2020 | $70778.00 | $-2.70M | -66.40% | -4,425.10% | -3,809.09% |
| 2021 | $0.00 | $-4.07M | — | — | — |
| 2022 | $0.00 | $-4.43M | — | — | — |
| 2023 | $0.00 | $-7.10M | — | — | — |
| 2024 | $0.00 | $-22.60M | — | — | — |
| 2025 | $0.00 | $-19.39M | — | — | — |
Frequently asked questions
How much free cash flow does GCTK generate?
GCTK produced $-15.34M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is GCTK's balance sheet healthy?
GCTK holds $7.38M in cash and equivalents against $231000.00 in long-term debt, on $2.83M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.